Trial
NCT00491387
Sympathetic Nervous System Modulation in Hypertension
Phase IVTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of Cincinnati
Collaborators
—
Condition
Hypertension
Intervention
Metoprolol Succinate
Why stopped
Adverse events reported with beta-blockers as primary therapy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-07